CTOs on the Move

MedLite ID

www.medliteid.com

 
MedLite ID is an easy-to-use, disposable medical device that enables clinicans to accurately and efficiently identify a single medication infusion line against similar infusion lines in any light setting. The ninth leading cause of medical-error deaths in the United States involves infusion line confusion, and nearly 65 percent of those cases are related to the medication infusion line. MedLite ID eliminates infusion confusion by providing indicators with built-in wireless light technology at the medication bag, connector, and to patient. Each MedLite ID device is unique to its individual medication infusion line and cuts the process of infusion line identification to ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medliteid.com
  • Atwood Innovation Plaza Suite 108 453 S 600 E.
    St. George, UT USA 84770
  • Phone: 435.652.7741

Executives

Name Title Contact Details
Steven Savage
Chief Operating Officer Profile

Similar Companies

Mississippit Valley Regional Blood Center

Mississippit Valley Regional Blood Center is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Teleflex

Teleflex is a global provider of medical devices used in critical care and surgery. We serve healthcare providers with specialty devices for vascular access, general and regional anesthesia, urology, respiratory care, cardiac care and surgery.

Young Dental

Young Dental is a Earth City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.

Acara MedSpas

Acara MedSpas is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.